IntuitionLabs logo

IntuitionLabs

AI solutions for pharmaceutical and life science operations, including drug discovery acceleration, sales analytics, and regulatory compliance.

Visit website

Overview

IntuitionLabs develops AI software solutions for pharmaceutical and life science organizations. The company focuses on helping these organizations optimize commercial operations, accelerate drug discovery and development workflows, and maintain regulatory compliance throughout digital transformation initiatives.

IntuitionLabs serves pharmaceutical and life science companies seeking to adopt AI, advanced analytics, and enterprise software platforms. The company positions itself at the intersection of technology implementation and industry-specific compliance requirements, offering both product-level AI solutions and broader consulting and managed services.

Core Services

  • Veeva Services and Solutions: Implementation, customization, and extensions for Veeva CRM, Vault, X-Pages/MyInsights, and Nitro. IntuitionLabs holds official Veeva Vault CRM X-Pages Partner status.
  • AI and Analytics Solutions: Development and deployment of AI and generative AI tools covering KOL segmentation, chatbots, and sales operations analytics.
  • Data Engineering and Business Intelligence: Building data pipelines, integration layers, data warehousing, and BI reporting to support operational decision-making.
  • Implementation and Integration: End-to-end implementation and integration of complex enterprise systems using structured methodologies.
  • Advisory and Consulting: Strategic guidance on digital transformation planning, AI adoption strategies, and technology roadmapping.
  • Managed Services: Ongoing IT management, system support, security, and compliance management for critical enterprise systems.

AI-Powered Products

  • Medical Info Chatbot: An AI-powered chatbot designed to deliver compliant medical information to healthcare professionals in real time.
  • GenAI Sales Ops Assistant: A generative AI tool providing intelligent automation and operational insights for pharmaceutical sales teams.
  • KOL Segmentation: An advanced analytics solution for identifying and engaging key opinion leaders within the pharmaceutical market.

Key Platform Capabilities

  • Regulatory Compliance: Solutions are built with compliance requirements in mind, covering FDA, EMA, and other global regulatory frameworks.
  • Enterprise Integration: Tools are designed to integrate with existing enterprise systems and workflows without significant disruption.
  • Data Security: Enterprise-grade security and privacy protections are incorporated across the platform.

Notable Customer Work

  • IntuitionLabs worked with Scilex Holding Company to transform their field sales analytics using custom Veeva MyInsights dashboards powered by Veeva Nitro.
  • The solution integrated real-time data from multiple sources to deliver actionable insights for both field teams and executive stakeholders.

Industry Context Referenced

  • AI-enhanced drug discovery and development can accelerate timelines by up to 60%, according to Deloitte research cited by the company.
  • McKinsey estimates AI will generate over $100 billion in annual value for the pharmaceutical industry by 2025.
  • Organizations implementing AI in commercial operations report 25–45% efficiency improvements in field force activities.
  • The pharmaceutical digital platform market is projected to grow from $4.92 billion in 2024 to $34.12 billion by 2032, at a CAGR of 24.35%, based on Grand View Research data.
  • Approximately 80% of pharmaceutical companies are already using cloud computing, with 95% expected to be fully cloud-operational within two years, per PwC data referenced on the site.
  • Implementation timelines for digital solutions in pharma range from 3–6 months for modular SaaS deployments to 9–18 months for full-suite implementations.

IntuitionLabs combines Veeva ecosystem expertise with proprietary AI tooling and broader data engineering capabilities, targeting pharmaceutical and life science companies navigating enterprise digital transformation under regulatory constraints.